2026: The Industrial Epoch Where Biology, AI, and Space Converge

2026 marks the definitive transition from artisanal gene editing to industrialized precision medicine, anchored by the first successful in vivo CRISPR treatment of a child. This year inaugurates a new systemic epoch where autonomous AI agents drive discovery, liquid biopsies redefine oncology, and cislunar strategy reshapes global geopolitics.